Type 2 diabetes (T2D) is characterized by worsening pancreatic β‐cell function often requiring treatment escalation with oral antidiabetic drugs (OADs), glucagon‐like peptide‐1 and eventually insulin. Here, INS is linked to type 2 diabetes mellitus.